Skip to content

Meditation App Use May Decrease State Anxiety

Leslie Burton, Amanda Tatnall, Aedan Frumento

Journal of Educational, Cultural and Psychological Studies January 29, 2026 DOI: 10.7358/ecps-2025-032-burt (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 75
Population Undergraduate students
Measures State Trait Anxiety Inventory (STAI)
Topics Anxiety Meditation
Key findings The meditation group had lower state anxiety after the 13-minute guided meditation than the control group after waiting.

Abstract

Abstract The goal of this study was to evaluate the relationship between a meditation app and anxiety. The effect of a free 13 minute guided meditation exercise (Take a Break!) on State Trait Anxiety Inventory (STAI) scores was evaluated in a normative sample of 75 undergraduate students. The only significant group difference was for state anxiety after intervention, such that the meditation group had lower state anxiety after meditation than the control group after waiting. This is an important finding because everyday life presents many challenges that increase anxiety, and having a tool that simply takes a 13 minute break is very valuable. Most people of all ages always have a cell phone with them which would make the this app very available in times of stress. This very brief intervention could be used in many settings, such as work, schools, sports, and home. Having a tool that has been validated empirically would give great credibility to suggesting it’s use in these settings.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics